 Ellen Elias
Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smith-Lemli-Opitz Syndrome | 15 | 2017 | 17 | 1.410 |
Why?
| | Disabled Children | 5 | 2021 | 69 | 0.970 |
Why?
| | Neurodevelopmental Disorders | 2 | 2020 | 110 | 0.740 |
Why?
| | Cholesterol | 15 | 2010 | 367 | 0.660 |
Why?
| | Health Services Needs and Demand | 3 | 2017 | 243 | 0.630 |
Why?
| | Nuclear Proteins | 2 | 2020 | 591 | 0.610 |
Why?
| | Transitional Care | 1 | 2017 | 34 | 0.540 |
Why?
| | Phenotype | 6 | 2019 | 2797 | 0.520 |
Why?
| | Autism Spectrum Disorder | 5 | 2021 | 322 | 0.510 |
Why?
| | Carrier Proteins | 1 | 2019 | 695 | 0.500 |
Why?
| | Developmental Disabilities | 4 | 2021 | 237 | 0.490 |
Why?
| | Quality Assurance, Health Care | 1 | 2017 | 311 | 0.470 |
Why?
| | Abnormalities, Multiple | 12 | 2018 | 178 | 0.470 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 7 | 2017 | 20 | 0.430 |
Why?
| | Health Services Accessibility | 2 | 2017 | 763 | 0.430 |
Why?
| | Home Care Services, Hospital-Based | 1 | 2012 | 10 | 0.400 |
Why?
| | Self-Help Devices | 1 | 2012 | 18 | 0.400 |
Why?
| | Equipment and Supplies | 1 | 2012 | 38 | 0.390 |
Why?
| | Interdisciplinary Communication | 2 | 2014 | 183 | 0.390 |
Why?
| | Mutation | 5 | 2020 | 3346 | 0.390 |
Why?
| | Facies | 4 | 2020 | 20 | 0.390 |
Why?
| | Cooperative Behavior | 2 | 2014 | 381 | 0.360 |
Why?
| | Autistic Disorder | 2 | 2010 | 162 | 0.350 |
Why?
| | Child, Preschool | 27 | 2020 | 9118 | 0.330 |
Why?
| | Child | 33 | 2023 | 18420 | 0.320 |
Why?
| | Craniofacial Abnormalities | 2 | 2019 | 59 | 0.320 |
Why?
| | Psychosexual Development | 1 | 2006 | 3 | 0.270 |
Why?
| | Sexuality | 1 | 2006 | 19 | 0.270 |
Why?
| | Chronic Disease | 1 | 2012 | 1578 | 0.260 |
Why?
| | Infant | 23 | 2020 | 7964 | 0.260 |
Why?
| | Intellectual Disability | 4 | 2020 | 128 | 0.260 |
Why?
| | Oxidoreductases | 6 | 2000 | 92 | 0.240 |
Why?
| | Adolescent | 24 | 2021 | 17853 | 0.240 |
Why?
| | Dehydrocholesterols | 7 | 2012 | 7 | 0.230 |
Why?
| | Infant, Newborn | 14 | 2018 | 5047 | 0.230 |
Why?
| | Retinal Rod Photoreceptor Cells | 1 | 2003 | 11 | 0.230 |
Why?
| | Vision, Ocular | 1 | 2003 | 30 | 0.220 |
Why?
| | Dwarfism | 1 | 2023 | 15 | 0.220 |
Why?
| | Osteochondrodysplasias | 1 | 2023 | 15 | 0.220 |
Why?
| | Retinal Diseases | 1 | 2003 | 76 | 0.210 |
Why?
| | Face | 4 | 2020 | 164 | 0.200 |
Why?
| | Retinoblastoma-Binding Protein 2 | 1 | 2020 | 3 | 0.180 |
Why?
| | Genetic Association Studies | 2 | 2019 | 339 | 0.180 |
Why?
| | Sexual Health | 1 | 2021 | 46 | 0.180 |
Why?
| | Humans | 45 | 2023 | 114699 | 0.170 |
Why?
| | Mutation, Missense | 2 | 2020 | 293 | 0.160 |
Why?
| | Cerebellum | 1 | 1999 | 200 | 0.150 |
Why?
| | Syndrome | 9 | 2020 | 333 | 0.150 |
Why?
| | Electroretinography | 2 | 2010 | 40 | 0.140 |
Why?
| | Female | 35 | 2021 | 59520 | 0.140 |
Why?
| | Repressor Proteins | 1 | 2020 | 366 | 0.140 |
Why?
| | Premature Birth | 1 | 2020 | 276 | 0.140 |
Why?
| | Heart Defects, Congenital | 3 | 1999 | 671 | 0.140 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 512 | 0.140 |
Why?
| | Communication Barriers | 1 | 2017 | 89 | 0.130 |
Why?
| | Metabolism, Inborn Errors | 1 | 1995 | 39 | 0.130 |
Why?
| | Male | 24 | 2020 | 55606 | 0.130 |
Why?
| | Child Nutrition Disorders | 1 | 2014 | 16 | 0.120 |
Why?
| | Genetic Predisposition to Disease | 2 | 2020 | 2086 | 0.120 |
Why?
| | Puberty, Precocious | 1 | 1994 | 13 | 0.110 |
Why?
| | Malnutrition | 1 | 2014 | 62 | 0.110 |
Why?
| | Cognition | 2 | 2020 | 989 | 0.110 |
Why?
| | Child Abuse, Sexual | 2 | 2021 | 81 | 0.110 |
Why?
| | Meningomyelocele | 1 | 1994 | 55 | 0.110 |
Why?
| | Contraception Behavior | 2 | 2021 | 81 | 0.110 |
Why?
| | Enteral Nutrition | 1 | 2014 | 160 | 0.110 |
Why?
| | Cognitive Dysfunction | 1 | 2017 | 284 | 0.100 |
Why?
| | Physician's Role | 2 | 2021 | 197 | 0.100 |
Why?
| | Blood Chemical Analysis | 1 | 2012 | 90 | 0.100 |
Why?
| | Brain | 2 | 2019 | 2371 | 0.100 |
Why?
| | DNA-Binding Proteins | 1 | 2018 | 1314 | 0.100 |
Why?
| | Down Syndrome | 1 | 2016 | 335 | 0.100 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2012 | 99 | 0.090 |
Why?
| | Transcription Factors | 1 | 2018 | 1528 | 0.090 |
Why?
| | Hamartoma Syndrome, Multiple | 1 | 2010 | 12 | 0.090 |
Why?
| | Megalencephaly | 1 | 2010 | 15 | 0.090 |
Why?
| | Retinal Cone Photoreceptor Cells | 1 | 2010 | 14 | 0.090 |
Why?
| | PTEN Phosphohydrolase | 1 | 2010 | 140 | 0.080 |
Why?
| | Neurocutaneous Syndromes | 1 | 2009 | 3 | 0.080 |
Why?
| | Angelman Syndrome | 1 | 2009 | 8 | 0.080 |
Why?
| | Rett Syndrome | 1 | 2009 | 23 | 0.080 |
Why?
| | Fetal Alcohol Spectrum Disorders | 1 | 2009 | 21 | 0.080 |
Why?
| | Bile Acids and Salts | 4 | 1997 | 171 | 0.080 |
Why?
| | Fragile X Syndrome | 1 | 2009 | 65 | 0.080 |
Why?
| | Growth Disorders | 3 | 1999 | 77 | 0.080 |
Why?
| | Internship and Residency | 1 | 2017 | 926 | 0.070 |
Why?
| | Thyroid Neoplasms | 1 | 2010 | 264 | 0.070 |
Why?
| | Patient-Centered Care | 1 | 2012 | 473 | 0.070 |
Why?
| | Adult | 13 | 2018 | 30553 | 0.070 |
Why?
| | Patient Readmission | 1 | 2012 | 610 | 0.070 |
Why?
| | Chromosome Deletion | 2 | 1997 | 95 | 0.070 |
Why?
| | Sex Education | 1 | 2006 | 30 | 0.070 |
Why?
| | Patient Discharge | 1 | 2012 | 773 | 0.070 |
Why?
| | Pregnancy | 4 | 2021 | 5520 | 0.060 |
Why?
| | Child, Exceptional | 1 | 2005 | 2 | 0.060 |
Why?
| | Aortic Stenosis, Subvalvular | 1 | 2005 | 4 | 0.060 |
Why?
| | Heterozygote | 2 | 1996 | 251 | 0.060 |
Why?
| | Marfan Syndrome | 1 | 2005 | 42 | 0.060 |
Why?
| | Craniosynostoses | 1 | 2005 | 28 | 0.060 |
Why?
| | Lipid Metabolism, Inborn Errors | 2 | 1995 | 16 | 0.060 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2005 | 79 | 0.060 |
Why?
| | Self Concept | 1 | 2006 | 214 | 0.060 |
Why?
| | Tetralogy of Fallot | 1 | 2005 | 81 | 0.060 |
Why?
| | Agenesis of Corpus Callosum | 1 | 2003 | 12 | 0.060 |
Why?
| | Parent-Child Relations | 1 | 2006 | 235 | 0.060 |
Why?
| | Follow-Up Studies | 4 | 2005 | 4411 | 0.060 |
Why?
| | Glypicans | 1 | 2023 | 9 | 0.050 |
Why?
| | Sterols | 4 | 1997 | 17 | 0.050 |
Why?
| | Interpersonal Relations | 1 | 2006 | 341 | 0.050 |
Why?
| | Genetic Variation | 2 | 2018 | 870 | 0.050 |
Why?
| | Siblings | 1 | 2023 | 221 | 0.050 |
Why?
| | Hand Deformities, Congenital | 2 | 2018 | 8 | 0.050 |
Why?
| | Hedgehog Proteins | 1 | 2023 | 172 | 0.050 |
Why?
| | Cholestadienols | 2 | 1998 | 2 | 0.050 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2003 | 473 | 0.050 |
Why?
| | Menstruation | 1 | 2021 | 35 | 0.050 |
Why?
| | Genetic Counseling | 1 | 2021 | 65 | 0.050 |
Why?
| | Genetic Techniques | 1 | 2020 | 58 | 0.040 |
Why?
| | Spinal Dysraphism | 1 | 2021 | 42 | 0.040 |
Why?
| | Kinetics | 1 | 2003 | 1551 | 0.040 |
Why?
| | Puberty | 1 | 2021 | 135 | 0.040 |
Why?
| | Dandy-Walker Syndrome | 1 | 1999 | 7 | 0.040 |
Why?
| | Cholesterol, Dietary | 2 | 1997 | 15 | 0.040 |
Why?
| | Pediatricians | 1 | 2021 | 122 | 0.040 |
Why?
| | Caregivers | 1 | 2006 | 717 | 0.040 |
Why?
| | Sexually Transmitted Diseases | 1 | 2021 | 155 | 0.040 |
Why?
| | Growth Hormone | 1 | 1999 | 103 | 0.040 |
Why?
| | Patient Transfer | 1 | 2021 | 143 | 0.040 |
Why?
| | Beckwith-Wiedemann Syndrome | 1 | 1999 | 6 | 0.040 |
Why?
| | Skull | 1 | 2020 | 119 | 0.040 |
Why?
| | Micrognathism | 1 | 2018 | 10 | 0.040 |
Why?
| | Penetrance | 1 | 2018 | 27 | 0.040 |
Why?
| | Larynx | 1 | 1999 | 47 | 0.040 |
Why?
| | Amniocentesis | 1 | 1998 | 21 | 0.040 |
Why?
| | Pediatrics | 1 | 2006 | 981 | 0.040 |
Why?
| | Chromosome Breakage | 1 | 1998 | 21 | 0.040 |
Why?
| | Fanconi Anemia | 1 | 1998 | 9 | 0.040 |
Why?
| | Homozygote | 2 | 1995 | 187 | 0.040 |
Why?
| | Spinal Cord Injuries | 1 | 2021 | 174 | 0.040 |
Why?
| | Neck | 1 | 2018 | 85 | 0.040 |
Why?
| | Amniotic Fluid | 1 | 1998 | 64 | 0.040 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2018 | 100 | 0.040 |
Why?
| | Chromosomes, Human, Pair 22 | 1 | 1997 | 38 | 0.040 |
Why?
| | Exome | 1 | 2018 | 200 | 0.040 |
Why?
| | Hirschsprung Disease | 1 | 1999 | 90 | 0.040 |
Why?
| | Sexual Behavior | 1 | 2021 | 440 | 0.040 |
Why?
| | Intelligence Tests | 1 | 2017 | 58 | 0.040 |
Why?
| | Endocrine Glands | 1 | 1997 | 15 | 0.030 |
Why?
| | Piperazines | 2 | 1997 | 309 | 0.030 |
Why?
| | Growth | 1 | 1997 | 55 | 0.030 |
Why?
| | Microcephaly | 2 | 1994 | 51 | 0.030 |
Why?
| | Behavior | 1 | 1997 | 92 | 0.030 |
Why?
| | Fetal Death | 1 | 1996 | 50 | 0.030 |
Why?
| | United States | 1 | 2012 | 12186 | 0.030 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 1996 | 53 | 0.030 |
Why?
| | Genotype | 2 | 2017 | 1760 | 0.030 |
Why?
| | Enzyme Inhibitors | 2 | 1997 | 750 | 0.030 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 1995 | 31 | 0.030 |
Why?
| | Microsomes, Liver | 1 | 1995 | 55 | 0.030 |
Why?
| | Middle Aged | 3 | 2018 | 26738 | 0.030 |
Why?
| | Young Adult | 3 | 2020 | 10471 | 0.030 |
Why?
| | Mosaicism | 1 | 1996 | 61 | 0.030 |
Why?
| | Trisomy | 1 | 1996 | 68 | 0.030 |
Why?
| | Skin Diseases | 1 | 1997 | 122 | 0.030 |
Why?
| | Primary Health Care | 1 | 2005 | 1514 | 0.030 |
Why?
| | Kidney Diseases | 1 | 1999 | 350 | 0.030 |
Why?
| | Gastrointestinal Diseases | 1 | 1997 | 182 | 0.030 |
Why?
| | Child Development | 1 | 2019 | 385 | 0.030 |
Why?
| | Bone and Bones | 1 | 1997 | 279 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2020 | 2570 | 0.030 |
Why?
| | Nutritional Requirements | 1 | 2014 | 75 | 0.030 |
Why?
| | Cataract | 1 | 1997 | 185 | 0.030 |
Why?
| | Limb Deformities, Congenital | 1 | 1994 | 8 | 0.030 |
Why?
| | Anticholesteremic Agents | 1 | 1995 | 128 | 0.030 |
Why?
| | Menarche | 1 | 1994 | 49 | 0.030 |
Why?
| | Radiography | 3 | 2003 | 812 | 0.030 |
Why?
| | Professional-Family Relations | 1 | 2014 | 133 | 0.030 |
Why?
| | Animals | 4 | 2020 | 31708 | 0.030 |
Why?
| | Hydrocephalus | 1 | 1994 | 83 | 0.030 |
Why?
| | Blood Specimen Collection | 1 | 2012 | 31 | 0.030 |
Why?
| | Esters | 1 | 2012 | 61 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2012 | 470 | 0.020 |
Why?
| | Oxyphil Cells | 1 | 2010 | 2 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 1995 | 2218 | 0.020 |
Why?
| | Thyroidectomy | 1 | 2010 | 53 | 0.020 |
Why?
| | Severity of Illness Index | 3 | 2005 | 2540 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2012 | 412 | 0.020 |
Why?
| | Incidence | 1 | 1996 | 2313 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2012 | 923 | 0.020 |
Why?
| | Decision Making | 1 | 2014 | 782 | 0.020 |
Why?
| | Rats | 1 | 1995 | 4958 | 0.020 |
Why?
| | Comorbidity | 1 | 2010 | 1448 | 0.020 |
Why?
| | Economics, Medical | 1 | 2005 | 4 | 0.020 |
Why?
| | Hospital Departments | 1 | 2005 | 8 | 0.020 |
Why?
| | Laboratories, Hospital | 1 | 2005 | 13 | 0.020 |
Why?
| | Health Maintenance Organizations | 1 | 2005 | 93 | 0.020 |
Why?
| | Polymorphism, Genetic | 2 | 2000 | 610 | 0.020 |
Why?
| | Mice | 1 | 2020 | 14871 | 0.010 |
Why?
| | Hospital Costs | 1 | 2005 | 104 | 0.010 |
Why?
| | Costs and Cost Analysis | 1 | 2005 | 196 | 0.010 |
Why?
| | Specialization | 1 | 2005 | 115 | 0.010 |
Why?
| | Quality of Life | 1 | 2014 | 2353 | 0.010 |
Why?
| | Health Resources | 1 | 2005 | 122 | 0.010 |
Why?
| | Health Expenditures | 1 | 2005 | 171 | 0.010 |
Why?
| | Radionuclide Imaging | 1 | 2003 | 115 | 0.010 |
Why?
| | Hydrogen | 1 | 2003 | 59 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2003 | 12555 | 0.010 |
Why?
| | Needs Assessment | 1 | 2005 | 314 | 0.010 |
Why?
| | Echocardiography | 1 | 2005 | 553 | 0.010 |
Why?
| | Outpatients | 1 | 2005 | 326 | 0.010 |
Why?
| | Hospitals, Pediatric | 1 | 2005 | 480 | 0.010 |
Why?
| | Inpatients | 1 | 2005 | 380 | 0.010 |
Why?
| | Cardiac Catheterization | 1 | 2005 | 534 | 0.010 |
Why?
| | Medicaid | 1 | 2005 | 407 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 2 | 2003 | 3053 | 0.010 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2000 | 65 | 0.010 |
Why?
| | Exons | 1 | 2000 | 302 | 0.010 |
Why?
| | Polydactyly | 1 | 1999 | 6 | 0.010 |
Why?
| | Cytogenetic Analysis | 1 | 1999 | 29 | 0.010 |
Why?
| | DNA Mutational Analysis | 1 | 2000 | 372 | 0.010 |
Why?
| | Karyotyping | 1 | 1999 | 102 | 0.010 |
Why?
| | Nuclear Family | 1 | 1999 | 49 | 0.010 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 1998 | 124 | 0.010 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 1999 | 309 | 0.010 |
Why?
| | Ribs | 1 | 1997 | 29 | 0.010 |
Why?
| | Alleles | 1 | 2000 | 789 | 0.010 |
Why?
| | Models, Genetic | 1 | 2000 | 562 | 0.010 |
Why?
| | Arm | 1 | 1997 | 104 | 0.010 |
Why?
| | Reference Values | 1 | 1998 | 743 | 0.010 |
Why?
| | Hospitalization | 1 | 2005 | 1752 | 0.010 |
Why?
| | Spine | 1 | 1997 | 136 | 0.010 |
Why?
| | Pregnancy Outcome | 1 | 1998 | 337 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2005 | 2286 | 0.010 |
Why?
| | Leg | 1 | 1997 | 225 | 0.010 |
Why?
| | Colorado | 1 | 2005 | 4100 | 0.010 |
Why?
| | Clinical Protocols | 1 | 1997 | 233 | 0.010 |
Why?
| | Gestational Age | 1 | 1998 | 760 | 0.010 |
Why?
| | Cohort Studies | 1 | 2005 | 4895 | 0.010 |
Why?
| | Translocation, Genetic | 1 | 1995 | 95 | 0.010 |
Why?
| | Ultrasonography | 1 | 1998 | 634 | 0.010 |
Why?
| | Ursodeoxycholic Acid | 1 | 1994 | 20 | 0.010 |
Why?
| | Genes, Recessive | 1 | 1994 | 73 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 1997 | 951 | 0.010 |
Why?
| | Failure to Thrive | 1 | 1994 | 32 | 0.010 |
Why?
| | Fetal Growth Retardation | 1 | 1998 | 468 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1996 | 993 | 0.010 |
Why?
| | Feces | 1 | 1994 | 373 | 0.010 |
Why?
| | Liver | 1 | 1997 | 1637 | 0.000 |
Why?
| | Erythrocytes | 1 | 1994 | 591 | 0.000 |
Why?
| | Disease Models, Animal | 1 | 1997 | 3535 | 0.000 |
Why?
|
|
Elias's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|